Skip to content

KPV

asset

1 claim involving it · 0 statements attributed to it

Involved in

On Thursday, the panel voted 8-6 to add BPC-157 to the list for treating ulcerative colitis, to add KPV for wound healing and inflammatory conditions, and to add TB-500 for wound healing.

Statements attributed to it

Nothing in the record is attributed to this entity as a speaker.

Origin: first recognised while reading FDA advisory panel narrowly rejects compounding of one peptide, backs two others · 2026-09-11 07:34